Efficacy of Lenvatinib and Atezolizumab Bevacizumab Combination Therapy in Patients With Combined Hepatocellular-cholangiocarcinoma
Anticancer Research · 2025-03 · 45 (3) · 1117-1125
DOI: 10.21873/anticanres.17499 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Anticancer Research, online erschienen am 04.03.2025. Verfasst von Norikazu Tanabe und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan; norikazu@yamaguchi-u.ac.jp. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Bevacizumab, Bile Duct Neoplasms, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 10-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan; norikazu@yamaguchi-u.ac.jp.
- Division of Laboratory, Yamaguchi University Hospital, Yamaguchi, Japan.
- Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
- Department of Gastroenterology, Hiroshima University Hospital, Hiroshima, Japan.
- Department of Gastroenterology and Oncology, Institute of Biomedical Sciences, Tokushima University Graduate School of Medicine, Tokushima, Japan.
- Department of Gastroenterology and Neurology, Kagawa University, Kagawa, Japan.
Zitieren
APA
Tanabe, N., Saeki, I., Yamaoka, K., Kawaoka, T., Tomonari, T., Tani, J., Terashima, T., Kawamura, Y., Oka, S., Takayama, T., Kobara, H., Yamashita, T., Akuta, N., Yamasaki, T., & Takami, T. (2025). Efficacy of Lenvatinib and Atezolizumab Bevacizumab Combination Therapy in Patients With Combined Hepatocellular-cholangiocarcinoma. Anticancer Research, 45(3), 1117-1125. https://doi.org/10.21873/anticanres.17499
Vancouver
Tanabe N, Saeki I, Yamaoka K, Kawaoka T, Tomonari T, Tani J, et al. Efficacy of Lenvatinib and Atezolizumab Bevacizumab Combination Therapy in Patients With Combined Hepatocellular-cholangiocarcinoma. Anticancer Research. 2025;45(3):1117-1125. doi:10.21873/anticanres.17499
BibTeX
@article{Tanabe2025,
author = {Tanabe, Norikazu and Saeki, Issei and Yamaoka, Kenji and Kawaoka, Tomokazu and Tomonari, Tetsu and Tani, Joji and Terashima, Takeshi and Kawamura, Yusuke and Oka, Shiro and Takayama, Tetsuji and Kobara, Hideki and Yamashita, Taro and Akuta, Norio and Yamasaki, Takahiro and Takami, Taro},
title = {Efficacy of Lenvatinib and Atezolizumab Bevacizumab Combination Therapy in Patients With Combined Hepatocellular-cholangiocarcinoma},
journal = {Anticancer Research},
year = {2025},
volume = {45},
number = {3},
pages = {1117--1125},
doi = {10.21873/anticanres.17499}
}
EUVIMED